Stock-Based Compensation (Tables)

9 Months Ended

Mar. 31, 2023

Share-Based Payment Arrangement [Abstract]

Summary of Nonvested Restricted Stock

The following table summarizes the status of the Company’s non-vested restricted stock awards and deferred stock awards since July 1, 2022:

	Non-vested Restricted Stock Awards
	Number of Shares	Weighted Average Grant Date Fair Value
Outstanding at July 1, 2022	2,305	$	57.47
Granted	269	54.52
Vested	(702)	60.81
Forfeited	(214)	55.74
Outstanding at March 31, 2023	1,658	$	55.08

Stock Based Compensation Expenses

The following table presents share-based compensation expenses included in the Company’s Consolidated Statements of Operations and Comprehensive Income (Loss):

	Third Quarters Ended				Nine Months Ended
	March 31, 2023		April 1, 2022		March 31, 2023		April 1, 2022
Cost of revenues	$	630	$	467	$	1,666	$	1,348
Selling, general and administrative	7,577		6,845		20,732		20,438
Research and development	1,732		1,575		5,048		4,476
Stock-based compensation expense before tax	9,939		8,887		27,446		26,262
Income taxes	(2,684)		(2,399)		(7,410)		(7,091)
Stock-based compensation expense, net of income taxes	$	7,255	$	6,488	$	20,036	$	19,171